Nine Months Ended
April 30, 2017

Attributable to IDT Corporation

Noncontrolling Interests

Total

(in thousands)

Balance, July 31, 2016

$

123,797

$

406

$

124,203

Dividends declared ($0.57 per share)

(13,155

)

—

(13,155

)

Sale of Class B common stock to Howard S. Jonas

10,000

—

10,000

Restricted Class B common stock purchased from employees

(1,838

)

—

(1,838

)

Exercise of stock options

835

—

835

Sale of interest and rights in Rafael Pharmaceuticals, Inc. to Howard S. Jonas (see Note 3)

(185

)

1,185

1,000

Issuance of member interests in CS Pharma Holdings, LLC (see Note 3)

1,850

8,150

10,000

Distributions to noncontrolling interests

—

(1,139

)

(1,139

)

Stock-based compensation

2,793

—

2,793

Comprehensive income:

Net income

18,018

1,081

19,099

Other comprehensive loss

(1,307

)

—

(1,307

)

Comprehensive income

16,711

1,081

17,792

Balance, April 30, 2017

$

140,808

$

9,683

$

150,491